Horizon 2020 Overview Jerome de Barros NCP Health
Basic concepts of Horizon 2020 The main European Union programme for research and innovation for A core part of Key European policy initiatives: – Europe 2020 – Innovation Union – Responding to the economic crisis to invest in jobs and growth – Strengthening the EU’s global position in Research, Innovation and technology
Three pillars
Health Research & Innovation in H2020
H2020 Research priorities 2016/2017 Personalised medicine Promoting Healthy Ageing Health ICT Human Biomonitoring
SC1 Work Programme 2016/2017 in brief Call “Personalised Medicine” - 21 Call topics: 34 in 2014/2015 (10 in 2016, 10 in 2017, 1 open in 2016 & 2017) - ‘Coordination activities (HCO)’ - 15 topics (17 in ): 12 in 2016, 3 in SME Instrument topics: Supporting innovative SMEs in the healthcare biotechnology sector (Cell technologies in medical applications and biomarkers) Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well Budget €500.17M (2016) €433.81M (2017)
Health Research & Innovation in H2020
Other H2020 Work Programme opportunities NMBP : Biomaterials for diagnosis and treatment of multiple sclerosis, RIA, (2 stage) NMBP : Nanoformulation of biologicals, RIA, (2 stage) NMBP : ERA-NET on Nanomedicine NMBP : Development of a reliable methodology for better risk management of engineered Biomaterials in Advanced Therapy Medicinal Products and/or Medical Devices, RIA, ( 2 stage) NMBP : Cross-KET for Health, RIA, ( 2 stage)
WP 2014/2015 stats Key Figures – €1.36 Billion EC Contribution – €1.69 Billion Total Project costs – Number of projects: 376 – Average contribution by projects: € – Number of participations: 2,863 – Number of organisations: – Average number of participants by project: 8
WP 2014/2015 stats
Jerome de Barros – Horizon 2020 Health NCP Mobile: 44(0)